Department of Rehabilitation Medicine, Hannover Medical School, Germany.
Vaccine. 2011 Sep 16;29(40):6830-3. doi: 10.1016/j.vaccine.2011.07.052. Epub 2011 Jul 29.
In the recent pandemic influenza A-(H1N1) v-2009 vaccination campaign, adjuvanted vaccines have been used because of their antigen-sparing effect. According to available reports, the rate of severe vaccination reactions has not increased, as compared with previous seasonal influenza vaccinations. Here we describe an adult female patient who was vaccinated with an AS03 adjuvanted split-virus vaccine injected into the left arm. She experienced a prolonged and painful local reaction for 4 weeks. During this time, persistent incapacitating pain shifted into the left shoulder. Magnetic resonance imaging (MRI) at the injection site detected atraumatic humeral head osteonecrosis in conjunction with bursitis of the rotator cuff region. Clinical and laboratory examination revealed no other underlying disease. Using analgetic medication and physical therapy, resting pain completely remitted within the following 14 weeks. Pain on exertion declined within the following 6 months. Atraumatic osteonecrosis, a relatively rare disorder which initially presents non-specific clinical symptoms, has never been associated with parenteral influenza vaccination. Although the available data cannot establish a causal relationship, our patient's clinical course - with a continuous transition from increased local post-vaccination reactions to symptoms of a severe shoulder lesion with osteonecrosis - raises the question of a pathogenetic link. Considering the vascular pathogenesis of osteonecrosis, we hypothesize that our patient's enhanced local immunologic reaction may have led to regional vasculitis as the cause of bone destruction. As mild forms of osteonecrosis may have escaped previous clinical attention, it is the purpose of our report to increase awareness of this exceptional event as a possible side effect of parenteral adjuvanted vaccination.
在最近的甲型流感 A(H1N1)v-2009 疫苗接种活动中,由于其抗原节约效应,使用了佐剂疫苗。根据现有报告,与以往季节性流感疫苗接种相比,严重疫苗接种反应的发生率并未增加。在这里,我们描述了一名成年女性患者,她在左臂接种了一种 AS03 佐剂的裂解病毒疫苗。她经历了长达 4 周的持久和疼痛的局部反应。在此期间,持续的使人丧失能力的疼痛转移到左肩。注射部位的磁共振成像(MRI)检测到非创伤性肱骨头骨坏死,同时伴有肩袖区域的滑囊炎。临床和实验室检查未发现其他潜在疾病。使用镇痛药和物理疗法,休息时疼痛在接下来的 14 周内完全缓解。在接下来的 6 个月内,运动时的疼痛有所下降。非创伤性骨坏死是一种相对罕见的疾病,最初表现出非特异性临床症状,从未与注射流感疫苗有关。尽管现有数据无法建立因果关系,但我们患者的临床病程——从持续增加的局部疫苗接种后反应到严重肩部病变和骨坏死的症状不断转变——提出了发病机制的问题。考虑到骨坏死的血管发病机制,我们假设我们患者增强的局部免疫反应可能导致了区域血管炎,这是骨破坏的原因。由于轻度骨坏死可能以前没有被临床注意到,因此我们报告的目的是提高对这种特殊事件作为注射佐剂疫苗的可能副作用的认识。